Overview

To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia

Status:
Active, not recruiting
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
Investigate the long-term(52 weeks) safety and efficacy of HSK16149 capsules in Chinese patients with periphcral neuralgia
Phase:
Phase 3
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.